Ethanol ablation of hepatocellular carcinoma up to 5.0 cm by using a multipronged injection needle with high-dose strategy

Radiology

Volumn 253, Issue 2, 2009, Pages 552-561

  Kuang, Ming ^a   Lu, Ming De ^a   Xie, Xiao Yan ^a   Xu, Hui Xiong ^a   Xu, Zuo Feng ^a   Liu, Guang Jian ^a   Yin, Xiao Yu ^a   Huang, Jie Fu ^b   Lencioni, Riccardo ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INFORMED CONSENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RISK FACTOR; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; ETHANOL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEEDLES; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77950113427     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2532082021     Document Type: Article

References (31)

1. Peto J. Cancer epidermiology in the last century and the next decades. Nature 2001;411: 390-395.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-750.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208 -1236.
4. Llovet JM, Fuster J, Bruix J; Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10(2 suppl 1):S115-S120.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
6. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360.
7. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197: 101-108.
8. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19: 323-328.
9. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-524.
10. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-800.
11. Lee WC, Jeng LB, Chen MF. Estimation of prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg 2002;89:311-316.
12. Jarnagin WR, Fong Y. Repeat resection for liver tumors. In: Clavien PA, ed. Malignant liver tumors: current and emerging therapies. Boston, Mass: Blackwell Science, 1999; 150-158.
13. Lu MD, Yin XY, Xie XY, et al. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005;92:1393-1398.
14. Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol 2005;43:377-380.
15. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999;210:655-661.
16. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
17. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004;127:1714-1723.
18. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130.
19. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radiofrequency ablation: complications encountered in a multicenter study. Radiology 2003; 226:441-451.
20. Llovet JM, Vilana R, Brú C, et al. Increased risk of tumor seeding after radiofrequency thermal ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-1129.
21. Curley SA, Marra P, Beaty K, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458.
22. Lencioni R, Cioni D, Crocetti L, et al. Earlystage hepatocellular carcinoma in cirrhosis: long term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234:961-967.
23. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005;43:458-464.
24. Hines-Peralta A, Liu ZJ, Horkan C, Solazzo S, Goldberg SN. Chemical tumor ablation with use of a novel multiple-tine infusion system in a canine sarcoma model. J Vasc Interv Radiol 2006;17:351-358.
25. Ho CS, Kachura JR, Gallinger S, et al. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety. Cardiovasc Intervent Radiol 2007;30:241-247.
26. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-739.
27. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 2004; 10(2 suppl 1):S91-S97.
28. Livraghi T. Role of percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Dig Dis 2001;19:292-300.
29. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004;10(2 suppl 1):S3-S8.
30. Izumi N, Asahina Y, Noguchi O, et al. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation. Cancer 2001;91:949-956.
31. Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 2002;89:57-62.